Pratyusha Ghanta

Dr. Pratyusha Ghanta

Biomedical Sciences, Kent State University, Kent, New York, USA
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Drug Delivery
Verified
Journal Article
Open access
PKPreeti Kumari
Preeti Kumari
OMOmkara Swami Muddineti
Omkara Swami Muddineti
SRSri Vishnu Kiran Rompicharla
Sri Vishnu Kiran Rompicharla
PGPratyusha Ghanta
Pratyusha Ghanta
ANAdithya Karthik B B N
Adithya Karthik B B N
SBSwati Biswas
Swati Biswas
Polymeric micelles have been widely explored preclinically as suitable delivery systems for poorly soluble chemotherapeutic drugs in cancer therapy. The present study reported the development of cholesterol (Ch)-conjugated poly(D,L-Lactide) (PLA)-based polymeric micelles (mPEG–PLA-Ch) for effective encapsulation and delivery of curcumin (CUR) at the tumor site. Cholesterol conjugation dramatically affected the particle size and improved drug loading (DL) and encapsulation efficiency (EE). mPEG–PLA-Ch-CUR showed bigger hydrodynamic diameter (104.6 ± 2.1 nm, and 169.3 ± 1.52 nm for mPEG–PLA and mPEG–PLA-Ch, respectively) due to increased size of the hydrophobic core. The newly developed polymer exhibited low critical micelles concentration (CMC) (25 μg/mL) which is close to lipid-based polymer, PEG-phosphatidyl ethanolamine (12.5 μg/mL) compared to mPEG–PLA (50 μg/mL). mPEG–PLA-Ch micelles exhibited relatively higher EE (93.74 ± 1.6%) and DL (11.86 ± 0.8%) compared to mPEG–PLA micelles (EE 91.89 ± 1.2% and DL 11.06 ± 0.8%). mPEG–PLA-Ch micelles were internalized by the cancer cells effectively and exhibited higher cytotoxicity compared to free CUR in both, murine melanoma (B16F10) and human breast cancer (MDA-MB-231) cells. mPEG–PLA-Ch exhibited satisfactory hemocompatibility indicating their potential for systemic application. Further, mPEG–PLA-Ch-CUR demonstrated higher rate of reduction of tumor volume in B16F10-xenografted tumor-bearing mice compared to free CUR. At the end of 22 days, the tumor reduced to 1.87-fold (627.72 ± 0.9 mm3 versus 1174.68 ± 1.64 mm3) compared to the treatment with free CUR. In conclusion, the experimental data in vitro and in vivo indicated that the newly developed CUR-mPEG–PLA-Ch micelles may have promising applications in solid tumors.

23 November 2016 in Nanomedicine
Verified
Journal Article
Closed access
SRSri Vishnu Kiran Rompicharla
Sri Vishnu Kiran Rompicharla
PTPrakruti Trivedi
Prakruti Trivedi
PKPreeti Kumari
Preeti Kumari
PGPratyusha Ghanta
Pratyusha Ghanta
BGBalaram Ghosh
Balaram Ghosh
SBSwati Biswas
Swati Biswas
Aim: To improve the bioavailability and anticancer potential of suberoylanilide hydroxamic acid (SAHA) by developing a drug-loaded polymeric nanomicellar system. Methods: SAHA-loaded Poly(ethylene glycol)-block-poly(caprolactone) (PEG-PCL) micelles were developed, and physico-chemically characterized. In vitro cellular uptake, viability and apoptosis-inducing ability of the SAHA-PEG-PCL micelles were investigated. In vivo anticancer activity was evaluated in C57BL/6 mice-bearing tumor. Results: The SAHA-PEG-PCL micelles had optimum size (∼130 nm) with an entrapment efficiency of approximately 67%. The SAHA-PEG-PCL induced stronger cell cycle arrest in G2/M phase leading to higher rate of apoptosis compared to free SAHA. SAHA-PEG-PCL demonstrated significant tumor suppression compared to free SAHA in vivo. Conclusion: The physicochemical properties and the antitumor efficacy of SAHA were improved by encapsulating in polymeric micelles.

1 February 2016 in Pharmacologia
Verified
Journal Article
Closed access
BVB. Veeresh
B. Veeresh
PGPratyusha Ghanta
Pratyusha Ghanta
SMS. Mallika
S. Mallika
KSK. Sudarshini
K. Sudarshini